Altria's Q3 Earnings Dip on Goodwill Impairment, Revenue Declines

TL;DR

**Altria's Q3 was a mixed bag: strong operating cash flow and dividend hikes can't fully mask the massive goodwill impairment and revenue slide, making it a hold for now.**

AI Summary

Altria Group, Inc. reported a decline in net revenues for the nine months ended September 30, 2025, falling to $17.433 billion from $18.044 billion in the prior year, a 3.39% decrease. Net earnings also significantly decreased to $5.830 billion for the nine-month period, down from $8.225 billion in 2024, representing a 29.12% drop. This decline was primarily driven by an $873 million impairment of goodwill in 2025 and the absence of the $2.700 billion gain on the sale of IQOS System commercialization rights recognized in 2024. Despite these challenges, the company's operating income for the three months ended September 30, 2025, increased slightly to $3.230 billion from $3.152 billion in 2024. Altria increased its quarterly dividend rate by 3.9% to $1.06 per share in August 2025, and authorized a $1.0 billion expansion to its share repurchase program, bringing the total to $2.0 billion expiring December 31, 2026. Cash provided by operating activities increased to $6.019 billion for the nine months ended September 30, 2025, up from $5.413 billion in 2024.

Why It Matters

Altria's significant decline in nine-month net earnings, largely due to a goodwill impairment and the absence of a prior-year asset sale gain, signals a challenging environment for investors. The company's continued dividend increases and expanded share repurchase program, however, demonstrate a commitment to shareholder returns amidst declining traditional tobacco sales. For employees and customers, the strategic shift towards e-vapor products through NJOY and the Horizon joint venture with Japan Tobacco Inc. indicates a long-term pivot away from core cigarette products, impacting future product development and market focus. The competitive landscape remains intense, with regulatory pressures on traditional tobacco and the evolving market for reduced-risk products.

Risk Assessment

Risk Level: medium — The company reported an $873 million impairment of goodwill for the nine months ended September 30, 2025, indicating potential overvaluation of past acquisitions or deteriorating business prospects. Additionally, net revenues decreased by 3.39% to $17.433 billion for the nine-month period, suggesting ongoing challenges in its core business segments.

Analyst Insight

Investors should monitor Altria's performance in its e-vapor and oral nicotine pouch segments, NJOY and Helix, as these are critical for future growth. While the dividend increase to $1.06 per share and expanded $2.0 billion share repurchase program offer some stability, the significant goodwill impairment and revenue decline warrant caution. Consider holding existing positions but deferring new investments until clearer signs of sustained growth in reduced-risk products emerge.

Financial Highlights

debt To Equity

-0.89

revenue

$17.433B

operating Margin

47.32%

total Assets

$35.008B

total Debt

$25.691B

net Income

$5.830B

gross Margin

62.59%

cash Position

$3.472B

revenue Growth

-3.39%

Key Numbers

• $17.433B — Net Revenues (Decreased from $18.044B in 2024 for the nine months ended September 30, 2025)
• $5.830B — Net Earnings (Decreased from $8.225B in 2024 for the nine months ended September 30, 2025)
• $873M — Goodwill Impairment (Recorded for the nine months ended September 30, 2025, impacting net earnings)
• $1.06 — Quarterly Dividend Rate (Increased by 3.9% from $1.02 per share in August 2025)
• $2.0B — Share Repurchase Program (Expanded from $1.0B, expiring December 31, 2026)
• $6.019B — Net Cash Provided by Operating Activities (Increased from $5.413B in 2024 for the nine months ended September 30, 2025)
• 12.3M — Shares Repurchased (For the nine months ended September 30, 2025, at an aggregate cost of $712M)
• $3.472B — Cash and Cash Equivalents (As of September 30, 2025, up from $3.127B at December 31, 2024)
• $24.132B — Long-term Debt (As of September 30, 2025, up from $23.399B at December 31, 2024)
• 29.12% — Net Earnings Decrease (Percentage decrease for the nine months ended September 30, 2025, compared to 2024)

Key Players & Entities

• ALTRIA GROUP, INC. (company) — Registrant
• Philip Morris USA Inc. (company) — Wholly owned subsidiary engaged in cigarette manufacturing and sale
• NJOY, LLC (company) — Wholly owned subsidiary engaged in e-vapor product manufacturing and sale
• Horizon Innovations LLC (company) — Joint venture for U.S. marketing and commercialization of heated tobacco stick products
• Anheuser-Busch InBev SA/NV (company) — Company in which Altria holds an investment
• Japan Tobacco Inc. (company) — Parent company of JTI (US) Holding, Inc., Altria's joint venture partner
• $17.433 billion (dollar_amount) — Net revenues for the nine months ended September 30, 2025
• $5.830 billion (dollar_amount) — Net earnings for the nine months ended September 30, 2025
• $873 million (dollar_amount) — Impairment of goodwill for the nine months ended September 30, 2025
• $1.06 (dollar_amount) — Increased quarterly dividend rate per share

FAQ

Risk Factors

• Changing Consumer Preferences and Product Innovation [high — regulatory]: Altria faces risks from evolving consumer preferences towards reduced-risk products and the need for continuous innovation. Failure to adapt to these shifts, particularly in the face of competition from new entrants and alternative products, could negatively impact market share and revenue. The company's significant investments in these areas require careful management to ensure successful market penetration and profitability.
• Government Regulation and Taxation [high — regulatory]: The tobacco industry is subject to extensive and evolving government regulation, including restrictions on marketing, sales, and product content. Increased excise taxes and potential new regulations on product categories like e-cigarettes and heated tobacco could significantly impact sales volumes and profitability. For example, excise taxes on products were $2.373 billion for the nine months ended September 30, 2025.
• Litigation and Legal Proceedings [high — legal]: Altria is involved in ongoing litigation related to its products, including claims concerning health effects. Adverse legal judgments or settlements could result in substantial financial liabilities. The company's settlement charges were $1.887 billion as of September 30, 2025.
• Debt Obligations and Financial Leverage [medium — financial]: Altria carries a significant amount of long-term debt, totaling $24.132 billion as of September 30, 2025. High leverage can increase financial risk, particularly in a rising interest rate environment or if the company's cash flows are negatively impacted. Interest and other debt expense, net was $815 million for the nine months ended September 30, 2025.
• Supply Chain Disruptions [medium — operational]: Disruptions in the supply chain for raw materials, manufacturing, or distribution could impact Altria's ability to meet demand. Global events, geopolitical instability, or labor issues can exacerbate these risks. Inventories, including leaf tobacco, were $1.065 billion as of September 30, 2025.
• Competition in Reduced-Risk Products [medium — market]: The market for reduced-risk products is highly competitive, with established players and new entrants vying for market share. Altria's success in this segment depends on its ability to develop and commercialize innovative products that gain consumer acceptance and regulatory approval, while facing intense competition.
• Goodwill Impairment [medium — financial]: Altria recorded an $873 million impairment of goodwill for the nine months ended September 30, 2025. This indicates that the carrying value of goodwill on the balance sheet exceeded its implied fair value, suggesting a potential overpayment for past acquisitions or a decline in the performance of acquired businesses. Goodwill decreased from $6.945 billion to $6.072 billion.
• Dependence on Traditional Tobacco Products [high — operational]: Despite diversification efforts, Altria remains heavily reliant on traditional tobacco products, which face secular declines in volume. A faster-than-anticipated decline in this core business, coupled with challenges in transitioning to new product categories, poses a significant risk to overall financial performance.

Industry Context

The tobacco industry is characterized by mature markets for traditional products and a significant shift towards reduced-risk alternatives. Altria operates in a highly competitive landscape, facing pressure from both established tobacco companies and new entrants in the RRP space. Regulatory scrutiny and evolving consumer preferences are key drivers shaping the industry's future.

Regulatory Implications

Altria faces substantial regulatory risks, including potential new taxes, marketing restrictions, and product standards for both traditional and reduced-risk products. Compliance with these evolving regulations is critical and can significantly impact sales volumes, costs, and profitability.

What Investors Should Do

1. [object Object]
2. [object Object]
3. [object Object]
4. [object Object]
5. [object Object]

Key Dates

• 2025-09-30: Nine months ended September 30, 2025 financial results reported — Revealed a 3.39% decrease in net revenues and a 29.12% drop in net earnings, largely due to an $873 million goodwill impairment and the absence of a prior year gain on sale.
• 2025-08-01: Quarterly dividend rate increased — Altria increased its quarterly dividend by 3.9% to $1.06 per share, signaling confidence in its cash flow generation and commitment to returning capital to shareholders.
• 2025-12-31: Share repurchase program expansion expiration — The expanded $2.0 billion share repurchase program, authorized in 2025, is set to expire on this date, indicating a potential future reduction in share count if fully utilized.
• 2024-09-30: Nine months ended September 30, 2024 financial results reported — Reported higher net revenues and net earnings compared to 2025, benefiting from a $2.700 billion gain on the sale of IQOS System commercialization rights.
• 2024-12-31: Previous year-end balance sheet date — Provides a baseline for comparison of assets and liabilities, showing an increase in cash and cash equivalents and long-term debt by September 30, 2025.

Glossary

Goodwill

An intangible asset that arises when one company acquires another for a price greater than the fair market value of its assets and liabilities. It represents the value of the acquired company's brand, customer base, and other intangible assets. (Altria recorded a significant $873 million impairment of goodwill in the nine months ended September 30, 2025, impacting net earnings and reflecting a decrease in the value of acquired businesses.)

Reduced-Risk Products (RRPs)

Products that may present less risk to the user's health compared to traditional combustible cigarettes, such as e-cigarettes and heated tobacco products. (Altria's strategy involves significant investment in RRPs, and their success is crucial for future growth and mitigating declines in traditional tobacco volumes.)

Excise Taxes

Taxes levied on the production, sale, or consumption of specific goods, often including tobacco products. (Excise taxes represent a substantial cost for Altria, amounting to $2.373 billion for the nine months ended September 30, 2025, and are subject to change by government regulation.)

Share Repurchase Program

A program where a company buys back its own shares from the open market, reducing the number of outstanding shares. (Altria expanded its share repurchase program to $2.0 billion, indicating a commitment to returning capital to shareholders and potentially boosting earnings per share.)

Operating Income

A company's earnings before interest and taxes (EBIT), representing profit from core business operations. (Operating income for the three months ended September 30, 2025, saw a slight increase to $3.230 billion, indicating resilience in core business profitability despite revenue declines.)

Net Revenues

The total revenue of a company after deducting returns, allowances, and discounts. (Net revenues for the nine months ended September 30, 2025, were $17.433 billion, a decrease of 3.39% from the prior year, highlighting a key challenge for the company.)

Net Earnings

The profit remaining after all expenses, including taxes and interest, have been deducted from total revenue. (Net earnings significantly decreased by 29.12% to $5.830 billion for the nine months ended September 30, 2025, primarily due to non-recurring items like goodwill impairment.)

Debt-to-Equity Ratio

A financial leverage ratio that indicates the proportion of a company's financing that comes from debt versus equity. (Altria's debt-to-equity ratio is negative due to its deficit in stockholders' equity, indicating a high level of financial leverage and reliance on debt financing.)

Year-Over-Year Comparison

Compared to the prior year, Altria reported a 3.39% decrease in net revenues for the nine months ended September 30, 2025, reaching $17.433 billion. Net earnings saw a substantial 29.12% decline to $5.830 billion, primarily due to an $873 million goodwill impairment and the absence of a significant gain from a prior year asset sale. While operating income for the quarter showed a slight increase, the overall trend indicates pressure on profitability. The company continues to manage its financial obligations, with long-term debt increasing to $24.132 billion, while also returning capital to shareholders through dividend increases and share repurchases.

Key Financial Figures

• $0.33 — ange on which registered Common Stock, $0.33 1/3 par value MO New York Stock Exchang

Filing Documents

• mo-20250930.htm (10-Q) — 2337KB
• exhibit22guarantorsubsidia.htm (EX-22) — 11KB
• exhibit311q32025-quarter.htm (EX-31.1) — 11KB
• exhibit312q32025-quarter.htm (EX-31.2) — 11KB
• exhibit321q32025-quarter.htm (EX-32.1) — 4KB
• exhibit322q32025-quarter.htm (EX-32.2) — 4KB
• exhibit991q32025-quarter.htm (EX-99.1) — 22KB
• exhibit992q32025-quarter.htm (EX-99.2) — 7KB
• 0000764180-25-000130.txt ( ) — 11814KB
• mo-20250930.xsd (EX-101.SCH) — 86KB
• mo-20250930_cal.xml (EX-101.CAL) — 78KB
• mo-20250930_def.xml (EX-101.DEF) — 525KB
• mo-20250930_lab.xml (EX-101.LAB) — 828KB
• mo-20250930_pre.xml (EX-101.PRE) — 734KB
• mo-20250930_htm.xml (XML) — 1854KB

- FINANCIAL INFORMATION

PART I - FINANCIAL INFORMATION

Financial Statements (Unaudited)

Item 1. Financial Statements (Unaudited) Condensed Consolidated Balance Sheets at September 30, 2025 and December 31, 2024 3 Condensed Consolidated Statements of Earnings for the Nine and Three Months Ended September 30, 2025 and 2024 5 Condensed Consolidated Statements of Comprehensive Earnings for the Nine and Three Months Ended September 30, 2025 and 2024 6 Condensed Consolidated Statements of Stockholders' Equity (Deficit) for the Nine Months Ended September 30, 2025 and 2024 7 Three Months Ended September 30, 2025 and 2024 8 Condensed Consolidated Statements of Cash Flows for the Nine Months Ended September 30, 2025 and 2024 9 Notes to Condensed Consolidated Financial Statements 11

Management's Discussion and Analysis of Financial Condition and Results of Operations

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations 37

Quantitative and Qualitative Disclosures About Market Risk

Item 3. Quantitative and Qualitative Disclosures About Market Risk 70

Controls and Procedures

Item 4. Controls and Procedures 70

- OTHER INFORMATION

PART II - OTHER INFORMATION

Legal Proceedings

Item 1. Legal Proceedings 70

Risk Factors

Item 1A. Risk Factors 70

Unregistered Sales of Equity Securities and Use of Proceeds

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 70

Other Information

Item 5. Other Information 71

Exhibits

Item 6. Exhibits 72 Signature Signature 73 2 Table of Contents

- FINANCIAL INFORMATION

PART I - FINANCIAL INFORMATION

Financial Statements

Item 1. Financial Statements Altria Group, Inc. and Subsidiaries Condensed Consolidated Balance Sheets (in millions of dollars) (Unaudited) ______________________________ September 30, 2025 December 31, 2024 Assets Cash and cash equivalents $ 3,472 $ 3,127 Receivables 249 177 Inventories: Leaf tobacco 502 591 Other raw materials 208 190 Work in process 19 21 Finished product 336 278 1,065 1,080 Other current assets 333 129 Total current assets 5,119 4,513 Property, plant and equipment, at cost 4,547 4,537 Less accumulated depreciation 2,930 2,920 1,617 1,617 Goodwill 6,072 6,945 Other intangible assets, net 12,866 12,973 Investments in equity securities 8,385 8,195 Other assets 949 934 Total Assets $ 35,008 $ 35,177 See notes to condensed consolidated financial statements. 3 Table of Contents Altria Group, Inc. and Subsidiaries Condensed Consolidated Balance Sheets (Continued) (in millions of dollars, except share and per share data) (Unaudited) ________________________________________________ September 30, 2025 December 31, 2024 Liabilities Current portion of long-term debt $ 1,569 $ 1,527 Accounts payable 662 700 Accrued liabilities: Marketing 886 688 Settlement charges 1,887 2,354 Other 1,495 1,780 Dividends payable 1,787 1,732 Total current liabilities 8,286 8,781 Long-term debt 24,132 23,399 Deferred income taxes 3,462 3,749 Accrued pension costs 133 136 Accrued postretirement health care costs 931 935 Other liabilities 660 365 Total liabilities 37,604 37,365 Contingencies (Note 14) Stockholders' Equity (Deficit) Common stock, par value $0.33 1/3 per share ( 2,805,961,317 shares issued) 935 935 Additional paid-in capital 5,906 5,905 Earnings reinvested in the business 36,115 35,516 Accumulated other comprehensive losses ( 2,709 ) ( 2,400 ) Cost of repurchased stock ( 1,126,809,622 shares at September 30, 2025 and 1,115,309,450 shares at December 31, 2024) ( 42,893 ) ( 42,194 ) Total stockholde